Pharmaceuticals

New Data from Phase 3 PAPILLON Study Show RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer

by

Data show the potential impact of RYBREVANT® and chemotherapy combination as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations Late-breaking data presented in a Presidential Symposium at 2023 ESMO Congress and simultaneously published in The New England Journal of Medicine MADRID, Oct. 21, 2023 /PRNewswire/ — … Read more

Avidity Biosciences Announces New Positive AOC 1001 Data Demonstrating Improvement in Multiple Additional Functional Endpoints and Favorable Long-term Safety and Tolerability in People with Myotonic Dystrophy Type 1

by

New AOC 1001 data demonstrate improvement in additional functional measures including hand grip, muscle strength and patient reported outcomes, augmenting previously reported positive data showing improvements in myotonia, muscle strength and mobility   New long-term safety data of AOC 1001 continue to demonstrate favorable safety and tolerability with over 200 infusions totaling 46.2 patient-years of … Read more

Enabling Pharmaceutical Company’s Success with Smart Automation in Integrated Manufacturing Process

by

NEW YORK, Sept. 8, 2023 /PRNewswire/ — Quantzig, a leading analytics advisory firm, once again proved its prowess in driving innovation and efficiency across industries. Through a groundbreaking smart automation initiative, we revolutionized the integrated manufacturing processes of a prominent pharmaceutical company, propelling them to new heights of productivity and excellence.   In a bid to address … Read more

National University Health System Launches World’s First Public Hospital’s Healthy Longevity Clinic at Alexandra Hospital

by

SINGAPORE, Sept. 2, 2023 /PRNewswire/ — The National University Health System (NUHS), NUS Yong Loo Lin School of Medicine and Alexandra Hospital (AH) have achieved a milestone by unveiling the world’s inaugural Healthy Longevity Clinic by public healthcare. Located at Singapore’s Alexandra Hospital, the clinic aims to delay biological ageing, thereby optimising functionality and resilience and … Read more

Tycoon Group Announces 2023 Interim Results

by

The Group’s Revenue Hits New HeightsNet profit for 1H2023 increased more than 2.8 times YoYBenefited from the Full Resumption of Normal TravelRevenue Continues to Generate Profit in Future Results Highlights Since the full resumption of normal travel between Hong Kong, Macau and Mainland China, the number of travellers has rebounded significantly, which is favourable for the … Read more

NRx Pharmaceuticals Announces Submission of an Investigational New Drug (IND) Application for NRX-101 in the Treatment of Chronic Pain

by

IND builds on previously-published, preliminary evidence of efficacy Filing is supported by robust manufacturing, pre-clinical and clinical data already reviewed by FDA for NRX-101 associated with treatment of bipolar depression RADNOR, Pa., Aug. 30, 2023 /PRNewswire/ – NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced submission an Investigational New … Read more

Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development

by

HONG KONG, Germantown, Md. and SUZHOU, China, July 27, 2023  /PRNewswire/ — Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that Dr. Francois Lebel, M.D., an experienced biopharmaceutical industry executive, has been appointed as Senior Vice President for preclinical and clinical development of the … Read more

Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

by

LUND, Sweden, July 12, 2023 /PRNewswire/ — Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced plans to restructure its operations. The company will cease commercialization of its IMMray PanCan-d test in the United States to focus its resources on the further development and clinical testing of the … Read more

Rise in Awareness Regarding CAR T-Cell Therapy Drives Growth

by

DUBLIN, July 6, 2023 /PRNewswire/ — The “CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen, By Indication, By Region, Segment Forecast, 2023-2032” report has been added to  ResearchAndMarkets.com’s offering. The global CAR-T cell therapy market size is expected to reach USD 118,680.68 million by 2032, according to a new study. This … Read more

FDA Roundup: June 16, 2023

by

SILVER SPRING, Md., June 16, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA posted information on its website regarding the formula for COVID-19 vaccines for the 2023-2024 fall and winter seasons. The FDA has advised manufacturers seeking to update … Read more